Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (öffnet neues Fenster)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Quelle‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Indiziert‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (öffnet neues Fenster)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (öffnet neues Fenster)

Banan M.

Quelle‎: Ann Hematol 2013;92(3):289-99.

Indiziert‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (öffnet neues Fenster)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (öffnet neues Fenster)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Quelle‎: Transfusion 2007;47(10):1830-6.

Indiziert‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (öffnet neues Fenster)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (öffnet neues Fenster)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Quelle‎: Blood 1996;87(3):887-92.

Indiziert‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (öffnet neues Fenster)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (öffnet neues Fenster)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Quelle‎: Iran J Blood Cancer 2009;1(4):147-50.

Indiziert‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (öffnet neues Fenster)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (öffnet neues Fenster)

Karimi M, Cohan N, Pishdad P.

Quelle‎: Hematology 2015;20(1):53-7.

Indiziert‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (öffnet neues Fenster)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (öffnet neues Fenster)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Quelle‎: Int J Hematol 2012;95(1):51-6.

Indiziert‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (öffnet neues Fenster)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (öffnet neues Fenster)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Quelle‎: Hemoglobin 2014;38(2):115-8.

Indiziert‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (öffnet neues Fenster)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (öffnet neues Fenster)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Quelle‎: Blood 2013;121(12):2199-212.

Indiziert‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (öffnet neues Fenster)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (öffnet neues Fenster)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Quelle‎: Sci Rep. 2022;12(1):2752.

Indiziert‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (öffnet neues Fenster)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (öffnet neues Fenster)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Quelle‎: Haematologica 2004;89(10):1172-8.

Indiziert‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (öffnet neues Fenster)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (öffnet neues Fenster)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Quelle‎: Arch Iran Med 2009;12(3):295-7.

Indiziert‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (öffnet neues Fenster)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (öffnet neues Fenster)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Quelle‎: Eur J Haematol 1996;56(5):326-8.

Indiziert‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (öffnet neues Fenster)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (öffnet neues Fenster)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Quelle‎: J Matern Fetal Med 1999;8(1):1-7.

Indiziert‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (öffnet neues Fenster)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (öffnet neues Fenster)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Quelle‎: Acta Haematol 2004;111(4):189-95.

Indiziert‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (öffnet neues Fenster)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (öffnet neues Fenster)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Quelle‎: Ann Hematol 2001;80(8):492-5.

Indiziert‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (öffnet neues Fenster)

Fetal globin induction--can it cure beta thalassemia? (öffnet neues Fenster)

Perrine SP.

Quelle‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Indiziert‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (öffnet neues Fenster)